CCC
CLDI icon

Cable Car Capital’s Calidi Biotherapeutics CLDI Stock Holding History

Cable Car Capital’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-432
Closed -$94.5K – 95
2024
Q3 		$94.5K Buy
432
+426
+7,100% +$119K 0.1% 50
2024
Q2 		$2.25K Sell
6
-240
-98% -$123K ﹤0.01% 58
2024
Q1 		$267K Sell
246
-35
-12% -$57.2K 0.37% 33
2023
Q4 		$814K Buy
+281
New +$1.21M 0.84% 21

Other funds holding CLDI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CI
CPR Investments Rochester, Michigan $130M AUM 29.56% 1-Year Est. Return
DWM
Drive Wealth Management Lehi, Utah $561M AUM 33.14% 1-Year Est. Return
RWI
Red Wave Investments Dillsburg, Pennsylvania $335M AUM 15.13% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cable Car Capital's CLDI Position: Q4 2024 in Review

Cable Car Capital sold out of Calidi Biotherapeutics (CLDI) in Q4 2024, closing a stake of 432 shares — an estimated $94.5K sold.

Cable Car Capital first reported a position in CLDI in Q4 2023 and held it in 4 quarters. The position peaked at $814K in Q4 2023. 33 funds tracked by Wall St. Rank hold CLDI as of Q4 2024.

  • Cable Car Capital reported no remaining Calidi Biotherapeutics position as of Q4 2024 after selling out during the quarter.
  • Cable Car Capital sold 432 Calidi Biotherapeutics shares in Q4 2024, an estimated $94.5K.
  • Cable Car Capital first reported a position in Calidi Biotherapeutics in Q4 2023 and held it in 4 quarters.
  • Cable Car Capital's Calidi Biotherapeutics position peaked at $814K in Q4 2023.
  • 33 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q4 2024.

Based on Cable Car Capital's 13F filing for Q4 2024, filed 14 Feb 2025.